扶桑薬品工業（4538）の空売り残高情報
空売りポジション
| 日付 | 報告 | 空売残高 | 増減率 | 株式数 |
|---|---|---|---|---|
| 2026 | ||||
| 02/16 | Barclays Capital Securities Ltd | 0.49% | -0.02% 義務消失 | 46,841株 -1,700株 |
| 02/12 | Barclays Capital Securities Ltd | 0.51% | 再IN | 48,541株 |
| 2025 | ||||
| 09/19 | Barclays Capital Securities Ltd | 0% | -1.13% 義務消失 | 0株 -107,441株 |
| 09/17 | Barclays Capital Securities Ltd | 1.13% | +0.1% | 107,441株 +9,400株 |
| 09/11 | Barclays Capital Securities Ltd | 1.03% | +0.13% | 98,041株 +12,700株 |
| 09/08 | Barclays Capital Securities Ltd | 0.9% | +0.08% | 85,341株 +7,500株 |
| 09/03 | Barclays Capital Securities Ltd | 0.82% | +0.11% | 77,841株 +10,500株 |
| 08/27 | Barclays Capital Securities Ltd | 0.71% | +0.11% | 67,341株 +10,600株 |
| 08/13 | Barclays Capital Securities Ltd | 0.6% | +0.07% | 56,741株 +6,500株 |
| 07/10 | Barclays Capital Securities Ltd | 0.53% | 新規 | 50,241株 |
| 2024 | ||||
| 01/16 | Nomura International plc | 0.43% | -0.09% 義務消失 | 41,300株 -7,900株 |
| 01/15 | Nomura International plc | 0.52% | 新規 | 49,200株 |
| 2023 | ||||
| 12/22 | MERRILL LYNCH INTERNATIONAL | 0.49% | -0.01% 義務消失 | 46,862株 -600株 |
| 12/21 | MERRILL LYNCH INTERNATIONAL | 0.5% | 再IN | 47,462株 |
| 12/20 | MERRILL LYNCH INTERNATIONAL | 0.49% | -0.01% 義務消失 | 46,662株 -1,300株 |
| 12/19 | MERRILL LYNCH INTERNATIONAL | 0.5% | -0.01% | 47,962株 -800株 |
| 12/18 | MERRILL LYNCH INTERNATIONAL | 0.51% | 新規 | 48,762株 |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
